Learn English: Regeneron's 23andMe Takeover: A Big Deal (normal)
3 days, 17 hours ago
Regeneron Pharmaceuticals, a major biotech firm, successfully acquired 23andMe in a $256 million deal.
This follows 23andMe's bankruptcy, raising concerns about the future of its genetic testing services.
The acquisition includes nearly all of 23andMe's assets, and DNA testing will continue as before.
Regeneron emphasizes its commitment to user privacy, ensuring compliance with data protection laws.
Learn English with En30s
Our simplified news summaries make learning English easy and efficient. Whether you're a beginner or an advanced learner, we have the right level for you. Choose from our easy, normal, or hard summaries and improve your English skills today!
